FBI Updates Credit Card Records Form
Published Date: 7/1/2026
Notice
Summary
The FBI’s Criminal Justice Information Services is updating its Credit Card Payment Form used by people requesting their own arrest or conviction records. They want your feedback on the new form and how easy it is to use before August 31, 2026. This update aims to make paying and getting your records smoother, with no extra costs expected.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
FBI Revises Credit Card Payment Form
You use the FBI Credit Card Payment Form (Form 1-786) when requesting a copy of your own arrest or conviction record from the FBI's Next Generation Identification system. The FBI estimates 36,385 people will use the form each year, it takes about 2 minutes to complete (totaling 1,213 annual burden hours) and an estimated $33,624.36 labor cost; the revision is intended to make paying and getting records smoother and the agency expects no extra costs. Public comments are being accepted through August 31, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-13364 — Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
Starting July 1, 2026, the DEA is temporarily putting four new substances—5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N-propionitrile chlorphine, and spirochlorphine—into Schedule I, the strictest drug category. This means anyone making, selling, or using these chemicals will face tough legal rules and penalties. The move helps keep these potentially dangerous drugs off the streets while the DEA studies them further.
2026-13150 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Patrick Leahy Bulletproof Vest Partnership Program
The Department of Justice is updating the paperwork for the Patrick Leahy Bulletproof Vest Partnership Program, which helps law enforcement get bulletproof vests. They want your feedback on the changes and how easy the new forms are to use. Comments are open for 30 days until July 30, 2026, so don’t miss your chance to weigh in!
2026-13145 — Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)
Almac Clinical Services Incorp. (ACSI) wants to become an official importer of certain controlled substances, including psilocybin and oxycodone. This affects drug manufacturers and others in the industry who can comment or request a hearing by July 30, 2026. No direct costs are mentioned, but the decision could impact how these substances enter the U.S. market.
Previous / Next Documents
Previous: 2026-13255 — Agency Information Collection Activities; Office of Public Health Disease Reporting and Surveillance Forms
The National Park Service wants to keep using its health and disease reporting forms to track illnesses in parks. They’re asking for public feedback by August 31, 2026, to make sure the forms aren’t too much work and still get the job done. This helps keep visitors safe without wasting time or money on paperwork.
Next: 2026-13257 — Decommission Remote Communications Outlets (RCOS) Used by Flight Service Stations Within the Conterminous United States, Hawaii, and Puerto Rico
The FAA is retiring 674 remote communication outlets (RCOs) used by pilots in the U.S., Hawaii, and Puerto Rico starting September 3, 2026. This change affects pilots relying on these stations for weather and flight info but keeps 262 outlets active to ensure safety and service. The move modernizes aviation communication without extra costs to users.